LOMITAPIDE
Tracking # 20-818931
$99999.00
There are no ratings for this course
Learn more Educator STATPEARLS PUBLISHING, LLC
CE Broker Reporting Reported automatically
Method Computer-Based Training
Course overview
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HOFH) MEDICATIONS COMPRISE MIPOMERSEN AND LOMITAPIDE. LOMITAPIDE IS AN FDA-APPROVED BESIDES A DIET LOW IN FATS, AND OTHER DRUGS USED TO REDUCE LIPIDS, TO DECREASE LOW-DENSITY LIPOPROTEIN (LDL) CHOLESTEROL, APOLIPOPROTEIN B, AND OTHER LIPOPROTEINS, IN PATIENTS SUFFERING FROM HOFH.
Subject areas
This course counts toward the state boards and subject areas below.
Florida Board of Osteopathic Medicine
Osteopathic Physician
1h
General